smoldering systemic mastocytosis
GPTKB entity
Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
hematologic disorder |
| gptkbp:affects |
immune system
hematopoietic system |
| gptkbp:cause |
KIT gene mutation
|
| gptkbp:has_diagnostic_criterion |
increased mast cells in bone marrow
organomegaly without dysfunction serum tryptase > 200 ng/mL |
| gptkbp:has_ICD-10_code |
D47.02
|
| https://www.w3.org/2000/01/rdf-schema#label |
smoldering systemic mastocytosis
|
| gptkbp:prevalence |
rare
|
| gptkbp:riskFactor |
progression to aggressive systemic mastocytosis
|
| gptkbp:symptom |
diarrhea
abdominal pain anaphylaxis bone pain flushing skin lesions |
| gptkbp:treatment |
corticosteroids
antihistamines cytoreductive therapy |
| gptkbp:type |
gptkb:systemic_mastocytosis
|
| gptkbp:bfsParent |
gptkb:systemic_mastocytosis
|
| gptkbp:bfsLayer |
6
|